Eyüpoğlu, Nesrin Damla, et al. “Event-Free Survival in Patients With Chronic Myeloid Leukemia Receiving Front-Line Imatinib Mesylate”. Acta Medica, vol. 53, no. 3, June 2022, pp. 277-83, https://doi.org/10.32552/2022.ActaMedica.745.